SupplySide Connect - Food Science & Ingredients Supplier Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Bened Biomedical Co.

The Leading Brand of Psychobiotics in Asia

Bened Biomedical was founded in 2015 in Taiwan, as a spin-out company from National Yang-Ming University (NYMU). It focuses on advanced technologies and products in microbiome-based therapy. Prof. Tsai, Ying-Chieh is the founder of Bened and a distinguished professor of the Institute of Biochemistry and Molecular Biology of NYMU and the director of Microbiome Research Center of NYMU. Bened has inherited this deep root and built a strong alliance with NYMU based on technical research and development by leveraging the university’s rich research resources. A milestone has been successfully completed to demonstrate the efficacy of Psychobiotic PS128®, along with a series of clinical studies scheduled across both human and animal health applications. Our vision is to develop functional probiotic strains that can alter human microbiome to maintain and optimize health. We chose the name “Bened”, which means “good blessing” in Latin, and expect the company to deliver blessing through our products and maximize the benefit to the global community. "Honor God, Serve The World " is our ultimate mission.

Trademarks

  • Bened Biomedical
  • PS128
  • InSeed
  • PS23
Trademarks
Brands
Bened Biomedical|Psychobiotics|PS128|PS23

Patents

LACTIC ACID BACTERIA, COMPOSITION CONTAINING IT, AND THEIR USE
To provide a method for preventing or treating functional gastrointestinal disorder in an individual.SOLUTION: The invention relates to an isolated lactic acid bacteria, Lactobacillus plantarum subspecies plantarum PS128 deposited at German Collection of Microorganisms and Cell Cultures (DSMZ) with accession number DSM 28632; a composition containing Lactobacillus plantarum subspecies plantarum PS128 and a carrier; and a method for preventing or treating stress induced malfunction and functional gastrointestinal disorder in an individual which comprises administering an effective amount of Lactobacillus plantarum subspecies plantarum PS128 to the individual.
Patent Number: JP-6035578 | Patent Date: 11/11/2016
Method for preventing or treating movement disorders with lactic acid bacterium
The invention surprisingly found that Lactobacillus plantarum subsp. plantarum PS128 provides an advantageous effect in treatment or prevention of tic disorders and basal ganglia disorders. Accordingly, the invention provides a method of treating or preventing a movement disorder in a subject, comprising administering to a subject an effective amount of cells of a Lactobacillus plantarum subsp. plantarum PS128, which is deposited under DSMZ Accession No. DSM 28632.
Patent Number: TW-I623319 | Patent Date: 05/11/2018
Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium
The present invention provides a method for preventing or treating a functional gastrointestinal disorder in a subject in need thereof that includes a step of administering a composition, wherein the composition includes an effective amount of Lactobacillus plantarum subsp. plantarum PS128 and a carrier. The present invention further provides a method for preventing or treating visceral hypersensitivity in a subject in need thereof that includes a step of administering a composition, wherein the composition includes an effective amount of Lactobacillus plantarum subsp. plantarum PS128 and a carrier. Moreover, the present invention provides a method for preventing or treating functional abdominal pain, irritable bowel syndrome or constipation in a subject in need thereof that includes a step of administering a composition, wherein the composition includes an effective amount of Lactobacillus plantarum subsp. plantarum PS128 and a carrier.
Patent Number: TW-I623318 | Patent Date: 05/11/2018
Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the same
The present invention provides an isolated lactic acid bacterium, Lactobacillus plantarum subsp. plantarum PS128 deposited under DSMZ Accession No. DSM 28632, for prophylaxis or treatment of a stress-induced disorder. The present invention further provides a composition for prophylaxis or treatment of a stress-induced disorder that comprises Lactobacillus plantarum subsp. plantarum PS128. Moreover, the present invention provides a method for prophylaxis or treatment of a stress-induced disorder in a subject that comprises a step of administering an effective amount of Lactobacillus plantarum subsp. plantarum PS128 to the subject.
Patent Number: TW-I509070 | Patent Date: 11/21/2015
Lactic Acid Bacterium, Composition Containing The Same And Their Use
The present invention provides an isolated lactic acid bacterium, Lactobacillus plantarum subsp. plantarum PS128 deposited under DSMZ Accession No. DSM 28632. The present invention further provides a composition that comprises Lactobacillus plantarum subsp, plantarum PS128 and a carrier. Moreover, the present invention provides a method for prophylaxis or treatment of a stress-induced disorder in a subject that comprises a step of administering an effective amount of Lactobacillus plantarum subsp. plantarum PS128 to the subject. The present invention also provides a method for prophylaxis or treatment of a functional gastrointestinal disorder in a subject that comprises a step of administering an effective amount of Lactobacillus plantarum subsp. plantarum PS128 to the subject.
Patent Number: EP-2937424 | Patent Date: 03/29/2017
Method for preventing or treating movement disorders with lactic acid bacterium
Patent Number: KR-10-1813881 | Patent Date: 12/26/2017
Lactic acid bacterium, composition containing the same and their use
To provide a method for preventing or treating functional gastrointestinal disorder in an individual.SOLUTION: The invention relates to an isolated lactic acid bacteria, Lactobacillus plantarum subspecies plantarum PS128 deposited at German Collection of Microorganisms and Cell Cultures (DSMZ) with accession number DSM 28632; a composition containing Lactobacillus plantarum subspecies plantarum PS128 and a carrier; and a method for preventing or treating stress induced malfunction and functional gastrointestinal disorder in an individual which comprises administering an effective amount of Lactobacillus plantarum subspecies plantarum PS128 to the individual.
Patent Number: CN-ZL 2015 1 0195767.9 | Patent Date: 09/14/2018
Exhibiting At: 
Category: 
Feedback